ERIN BLEVINS: Open Payments
NPI 1386429124 · DUBLIN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,285 in 202 payments from 20 companies in 2025. Trend: 2023 $234 · 2024 $2,489 · 2025 $3,285
Food & beverage: $3,185Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $822 |
| Janssen Biotech, Inc. | 49 | $716 |
| Organon LLC | 25 | $336 |
| Incyte Corporation | 10 | $260 |
| UCB, Inc. | 11 | $239 |
| Novartis Pharmaceuticals Corporation | 11 | $229 |
| Galderma Laboratories, L.P. | 15 | $179 |
| E.R. Squibb & Sons, L.L.C. | 3 | $75 |
| PFIZER INC. | 4 | $74 |
| Amgen Inc. | 3 | $56 |
Products named: TREMFYA, SKYRIZI, RINVOQ, OPZELURA, Bimzelx, COSENTYX, VTAMA, NEMLUVIO.
Industry payments across OH — which companies pay providers there.
